Coherus Oncology (CHRS)'s 30-day implied volatility (IV30) was 174.4% at the close on October 21, 2026, up from 75.9% the day before, against a 52-week range of 51.5% to 169.3%. Its 20-day historical volatility was 71.2%.
Data as of October 21, 2026.